Evidence mapPaperPMID 41640563Full record

ArticleAfrican health sciences2025

Effect of modified Shenqi pill combined with conventional western medicine on diabetic nephropathy and its influence on netrin-1 level and renal function.

Xiaoli Zhang, Cheng'e Gao, Xiaoshuang Yin

Abstract read
In one paragraph

Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoli ZhangDepartment of Endocrinology, Affiliated Hospital of Shandong University of traditional Chinese Medicine, Jinan, China.
Cheng'e GaoOutpatient Service Center, Affiliated Hospital of Shandong University of traditional Chinese Medicine, Jinan, China.
Xiaoshuang YinDepartment of Nephrology, Affiliated Hospital of Shandong University of traditional Chinese Medicine, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Our aim in this study was to investigate the efficacy of modified Shenqi pills combined with conventional western medicine in patients with diabetic nephropathy. Methodology: 150 patients with diabetic nephropathy were divided into a western medicine group (50 cases, conventional western medicine), a traditional Chinese medicine group (50 cases, modified Shenqi pills), and an observation group (50 cases, modified Shenqi pills combined with conventional western medicine). The values of netrin-1, 24-hour urinary protein, blood urea nitrogen (BUN), creatinine (Scr), symptom score, and clinical efficacy were compared among three groups before and after treatment. Results: The netrin-1, 24h urine protein, BUN and Scr values, the total score of main symptoms, and total score of secondary symptoms in the observation group were lower than those in the traditional Chinese medicine group and western medicine group at 3 months after treatment, and the difference was statistically significant. The total effective rate in the observation group (100.00%) was significantly higher than that in the traditional Chinese medicine group (86.00%) and western medicine group (78.00%), and the difference was statistically significant. Conclusion: Combination of modified Shenqi Pills with conventional western medicine can achieve a more satisfactory effect in diabetic nephropathy, by reducing Netrin-1, promoting renal function recovery, eliminating edema and decreasing blood pressure.

Indexed as

Diabetic NephropathiesDrugs, Chinese HerbalNetrin-1AdultAgedBlood Urea NitrogenCreatinineDrug Therapy, CombinationFemaleHumansKidneyMaleMedicine, Chinese TraditionalMiddle AgedTreatment OutcomeCreatinineDrugs, Chinese HerbalNetrin-1shenqicombined therapyDiabetic nephropathymodified Shenqi pillnerve guidance factor-1renal functionwestern medicine

Identifiers

PMID41640563
PMCPMC12865079

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.